Page last updated: 2024-09-05

migalastat and Hypertrophy, Left Ventricular

migalastat has been researched along with Hypertrophy, Left Ventricular in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cui, G; Huang, J; Wang, DW; Zeng, H; Zhou, C; Zhou, Q	1
Amartino, H; Banikazemi, M; Barlow, C; Barth, J; Benjamin, ER; Bichet, DG; Bratkovic, D; Castelli, J; Charrow, J; Dasouki, M; Ezgu, F; Feldt-Rasmussen, U; Feliciani, C; Finegold, D; Germain, DP; Giraldo, P; Giugliani, R; Goker-Alpan, O; Hughes, DA; Johnson, F; Jovanovic, A; Kirk, J; Lockhart, DJ; Longo, N; Lourenco, CM; Ludington, E; Nedd, K; Nicholls, K; Packman, S; Schiffmann, R; Scott, CR; Shankar, SP; Sharaf El Din, U; Skuban, N; Torra, R; Tuffaha, A; Viereck, C; Waldek, S; Wilcox, WR; Yu, J	1

Studies

Cui, G; Huang, J; Wang, DW; Zeng, H; Zhou, C; Zhou, Q

Amartino, H; Banikazemi, M; Barlow, C; Barth, J; Benjamin, ER; Bichet, DG; Bratkovic, D; Castelli, J; Charrow, J; Dasouki, M; Ezgu, F; Feldt-Rasmussen, U; Feliciani, C; Finegold, D; Germain, DP; Giraldo, P; Giugliani, R; Goker-Alpan, O; Hughes, DA; Johnson, F; Jovanovic, A; Kirk, J; Lockhart, DJ; Longo, N; Lourenco, CM; Ludington, E; Nedd, K; Nicholls, K; Packman, S; Schiffmann, R; Scott, CR; Shankar, SP; Sharaf El Din, U; Skuban, N; Torra, R; Tuffaha, A; Viereck, C; Waldek, S; Wilcox, WR; Yu, J

Trials

1 trial(s) available for migalastat and Hypertrophy, Left Ventricular

Article	Year
Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat. The New England journal of medicine, 2016, Aug-11, Volume: 375, Issue:6 Topics: 1-Deoxynojirimycin; Adolescent; Adult; Aged; alpha-Galactosidase; Diarrhea; Double-Blind Method; Fabry Disease; Female; Glomerular Filtration Rate; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Kidney; Male; Middle Aged; Mutation; Trihexosylceramides; Ultrasonography; Young Adult	2016

Article

Year

Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat.

The New England journal of medicine, 2016, Aug-11, Volume: 375, Issue:6

Topics: 1-Deoxynojirimycin; Adolescent; Adult; Aged; alpha-Galactosidase; Diarrhea; Double-Blind Method; Fabry Disease; Female; Glomerular Filtration Rate; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Kidney; Male; Middle Aged; Mutation; Trihexosylceramides; Ultrasonography; Young Adult

2016

Other Studies

1 other study(ies) available for migalastat and Hypertrophy, Left Ventricular

Article	Year
Identification of a novel loss-of-function mutation of the GLA gene in a Chinese Han family with Fabry disease. BMC medical genetics, 2018, 12-27, Volume: 19, Issue:1 Topics: 1-Deoxynojirimycin; Adult; Aged; alpha-Galactosidase; Asian People; Base Sequence; Child; Exons; Fabry Disease; Female; Gene Expression; Glycolipids; HEK293 Cells; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Loss of Function Mutation; Male; Middle Aged; Pedigree; Phenotype	2018

Article

Year

Identification of a novel loss-of-function mutation of the GLA gene in a Chinese Han family with Fabry disease.

BMC medical genetics, 2018, 12-27, Volume: 19, Issue:1

Topics: 1-Deoxynojirimycin; Adult; Aged; alpha-Galactosidase; Asian People; Base Sequence; Child; Exons; Fabry Disease; Female; Gene Expression; Glycolipids; HEK293 Cells; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Loss of Function Mutation; Male; Middle Aged; Pedigree; Phenotype

2018